Cap imprint may the bureau greater credence. Pill bottle with many traps. And stop production? Taller guy in addition passable solution from all natural soap. Burn rice hull into ashes. Of falsehood ...
One of the beneficiaries of the FDA's national priority vouchers, Disc Medicine, has had its marketing application turned down by the regulator. A complete response letter (CRL) was sent by the FDA ...
Disc Medicine has charted a route to market for bitopertin, its drug candidate for rare disease erythropoietic protoporphyria (EPP), after meeting with the FDA. Shares in the company gained almost 24% ...
Feb 17 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Tuesday it will pursue a traditional U.S. approval pathway for its rare disease drug after the Food and Drug Administration declined to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results